{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:17:16Z","timestamp":1793344636967,"version":"4.5.0"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI050234"],"award-info":[{"award-number":["AI050234"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R01 AI109023"],"award-info":[{"award-number":["R01 AI109023"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI124678"],"award-info":[{"award-number":["AI124678"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-006599"],"award-info":[{"award-number":["INV-006599"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Microbiology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.mib.2022.102193","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T13:43:52Z","timestamp":1661175832000},"page":"102193","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"special_numbering":"C","title":["Plasmodium falciparum resistance to artemisinin-based combination therapies"],"prefix":"10.1016","volume":"69","author":[{"given":"Kurt E","family":"Ward","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Fidock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L","family":"Bridgford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mib.2022.102193_bib1","unstructured":"World Health Organization. World malaria report 2021. https:\/\/www.who.int\/teams\/global-malaria-programme\/reports\/world-malaria-report-2021."},{"key":"10.1016\/j.mib.2022.102193_bib2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/QCO.0000000000000766","article-title":"Artemisinin and multidrug-resistant Plasmodium falciparum - a threat for malaria control and elimination","volume":"34","author":"Dhorda","year":"2021","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_bib3","unstructured":"World Health Organization. Report on antimalarial drug efficacy, resistance and response: 10 years of surveillance (2010-2019); 2020. https:\/\/www.who.int\/publications\/i\/item\/9789240012813."},{"key":"10.1016\/j.mib.2022.102193_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1056\/NEJMoa0808859","article-title":"Artemisinin resistance in Plasmodium falciparum malaria","volume":"361","author":"Dondorp","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2022.102193_bib5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1056\/NEJMc1403007","article-title":"Dihydroartemisinin-piperaquine failure in Cambodia","volume":"371","author":"Saunders","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2022.102193_bib6","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1473-3099(15)70049-6","article-title":"Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study","volume":"15","author":"Spring","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_bib7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1473-3099(16)30409-1","article-title":"Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study","volume":"17","author":"Amato","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_bib8","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S1473-3099(16)30415-7","article-title":"A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study","volume":"17","author":"Witkowski","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_bib9","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S1473-3099(19)30391-3","article-title":"Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study","volume":"19","author":"van der Pluijm","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pt.2020.09.011","article-title":"Triple artemisinin-based combination therapies for malaria - a new paradigm?","volume":"37","author":"van der Pluijm","year":"2021","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.mib.2022.102193_bib11","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1021\/jm00035a003","article-title":"Mechanism-based design, synthesis, and in vitro antimalarial testing of new 4-methylated trioxanes structurally related to artemisinin: the importance of a carbon-centered radical for antimalarial activity","volume":"37","author":"Posner","year":"1994","journal-title":"J Med Chem"},{"key":"10.1016\/j.mib.2022.102193_bib12","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/tropicalmed4020089","article-title":"Artemisinin-based antimalarial drug therapy: molecular pharmacology and evolving resistance","volume":"4","author":"Heller","year":"2019","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_bib13","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.chom.2017.11.005","article-title":"Inhibiting the Plasmodium eIF2\u03b1 kinase PK4 prevents artemisinin-induced latency","volume":"22","author":"Zhang","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.mib.2022.102193_bib14","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1038\/s41467-018-06221-1","article-title":"Artemisinin kills malaria parasites by damaging proteins and inhibiting the proteasome","volume":"9","author":"Bridgford","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2022.102193_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007722","article-title":"Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents","volume":"15","author":"Stokes","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2022.102193_bib16","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1038\/s41467-021-24814-1","article-title":"The apicoplast link to fever-survival and artemisinin-resistance in the malaria parasite","volume":"12","author":"Zhang","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2022.102193_bib17","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41564-021-00940-w","article-title":"A heat-shock response regulated by the PfAP2-HS transcription factor protects human malaria parasites from febrile temperatures","volume":"6","author":"Tinto-Font","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.mib.2022.102193_bib18","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02137-20","article-title":"Artemisinin-based drugs target the Plasmodium falciparum heme detoxification pathway","volume":"65","author":"Ribbiso","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2022.102193_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.pt.2020.03.006","article-title":"K13, the cytostome, and artemisinin resistance","volume":"36","author":"Xie","year":"2020","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.mib.2022.102193_bib20","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.3390\/molecules27061755","article-title":"The antagonizing role of heme in the antimalarial function of artemisinin: elevating intracellular free heme negatively impacts artemisinin activity in Plasmodium falciparum","volume":"27","author":"Zhu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.mib.2022.102193_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ijpddr.2021.05.007","article-title":"Plasmodium falciparum resistance to ACTs: emergence, mechanisms, and outlook","volume":"16","author":"Siddiqui","year":"2021","journal-title":"Int J Parasitol Drugs Drug Resist"},{"key":"10.1016\/j.mib.2022.102193_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01320-21","article-title":"Mutation in the Plasmodium falciparum BTB\/POZ domain of K13 protein confers artemisinin resistance","volume":"66","author":"Paloque","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2022.102193_bib23","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.1260867","article-title":"K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates","volume":"347","author":"Straimer","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.mib.2022.102193_sbref22","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41591-020-1005-2","article-title":"Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda","volume":"26","author":"Uwimana","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.mib.2022.102193_sbref23","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01134-19","article-title":"Role of Plasmodium falciparum Kelch 13 protein mutations in P. falciparum populations from Northeastern Myanmar in mediating artemisinin resistance","volume":"11","author":"Siddiqui","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.mib.2022.102193_bib26","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66277","article-title":"Plasmodium falciparum K13 mutations in Africa and Asia impact artemisinin resistance and parasite fitness","volume":"10","author":"Stokes","year":"2021","journal-title":"Elife"},{"key":"10.1016\/j.mib.2022.102193_bib27","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/science.1260403","article-title":"Population transcriptomics of human malaria parasites reveals the mechanism of artemisinin resistance","volume":"347","author":"Mok","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.mib.2022.102193_bib28","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41579-019-0238-x","article-title":"Protozoan persister-like cells and drug treatment failure","volume":"17","author":"Barrett","year":"2019","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.mib.2022.102193_sbref27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41467-020-20805-w","article-title":"Artemisinin-resistant K13 mutations rewire Plasmodium falciparum's intra-erythrocytic metabolic program to enhance survival","volume":"12","author":"Mok","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2022.102193_bib30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S1473-3099(13)70252-4","article-title":"Novel phenotypic assays for the detection of artemisinin-resistant Plasmodium falciparum malaria in Cambodia: in-vitro and ex-vivo drug-response studies","volume":"13","author":"Witkowski","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_bib31","article-title":"PfD123 modulates K13-mediated survival and recovery after artemisinin exposure","author":"N\u00f6tzel","year":"2022","journal-title":"bioRxiv"},{"key":"10.1016\/j.mib.2022.102193_bib32","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.celrep.2019.10.095","article-title":"Decreased K13 abundance reduces hemoglobin catabolism and proteotoxic stress, underpinning artemisinin resistance","volume":"29","author":"Yang","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.mib.2022.102193_sbref31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1126\/science.aax4735","article-title":"A Kelch13-defined endocytosis pathway mediates artemisinin resistance in malaria parasites","volume":"367","author":"Birnbaum","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.mib.2022.102193_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102177","article-title":"Protein abundance and folding rather than the redox state of Kelch13 determine the artemisinin susceptibility of Plasmodium falciparum","volume":"48","author":"Schumann","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.mib.2022.102193_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008482","article-title":"Insights into the intracellular localization, protein associations and artemisinin resistance properties of Plasmodium falciparum K13","volume":"16","author":"Gn\u00e4dig","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2022.102193_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.02782-21","article-title":"A leak-free inducible CRISPRi\/a system for gene functional studies in Plasmodium falciparum","volume":"10","author":"Liang","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.mib.2022.102193_bib37","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nmeth.4223","article-title":"A genetic system to study Plasmodium falciparum protein function","volume":"14","author":"Birnbaum","year":"2017","journal-title":"Nat Methods"},{"key":"10.1016\/j.mib.2022.102193_bib38","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1182\/blood-2017-11-814665","article-title":"Remodeling of the malaria parasite and host human red cell by vesicle amplification that induces artemisinin resistance","volume":"131","author":"Bhattacharjee","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.mib.2022.102193_bib39","doi-asserted-by":"crossref","first-page":"e02918","DOI":"10.1128\/mBio.02918-19","article-title":"The Plasmodium falciparum artemisinin susceptibility-associated AP-2 adaptin \u03bc subunit is clathrin independent and essential for schizont maturation","volume":"11","author":"Henrici","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.mib.2022.102193_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02484-19","article-title":"Experimentally engineered mutations in a ubiquitin hydrolase, UBP-1, modulate in vivo susceptibility to artemisinin and chloroquine in Plasmodium berghei","volume":"64","author":"Simwela","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2022.102193_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006930","article-title":"Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites","volume":"14","author":"Rocamora","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2022.102193_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.freeradbiomed.2021.08.016","article-title":"Resistance to artemisinin in falciparum malaria parasites: a redox-mediated phenomenon","volume":"179","author":"Egwu","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.mib.2022.102193_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107996","article-title":"K13-mediated reduced susceptibility to artemisinin in Plasmodium falciparum is overlaid on a trait of enhanced DNA damage repair","volume":"32","author":"Xiong","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.mib.2022.102193_bib44","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12936-016-1206-9","article-title":"Plasmodium falciparum: multifaceted resistance to artemisinins","volume":"15","author":"Paloque","year":"2016","journal-title":"Malar J"},{"key":"10.1016\/j.mib.2022.102193_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00753-21","article-title":"Restructured mitochondrial-nuclear interaction in Plasmodium falciparum dormancy and persister survival after artemisinin exposure","volume":"12","author":"Connelly","year":"2021","journal-title":"mBio"},{"key":"10.1016\/j.mib.2022.102193_bib46","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMc2117480","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"386","author":"Stokes","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2022.102193_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1009266","article-title":"Genetic background and PfKelch13 affect artemisinin susceptibility of PfCoronin mutants in Plasmodium falciparum","volume":"16","author":"Sharma","year":"2020","journal-title":"PLoS Genet"},{"key":"10.1016\/j.mib.2022.102193_bib48","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1473-3099(21)00142-0","article-title":"Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study","volume":"21","author":"Uwimana","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_sbref47","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1056\/NEJMoa2101746","article-title":"Evidence of artemisinin-resistant malaria in Africa","volume":"385","author":"Balikagala","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.mib.2022.102193_bib50","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1093\/infdis\/jiab352","article-title":"High prevalence of Plasmodium falciparum K13 mutations in Rwanda is associated with slow parasite clearance after treatment with artemether-lumefantrine","volume":"225","author":"Straimer","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_sbref49","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/S1473-3099(20)30228-0","article-title":"Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study","volume":"20","author":"Imwong","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_bib52","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51015","article-title":"Local emergence in Amazonia of Plasmodium falciparum k13 C580Y mutants associated with in vitro artemisinin resistance","volume":"9","author":"Mathieu","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.mib.2022.102193_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009133","article-title":"Emergence of artemisinin-resistant Plasmodium falciparum with kelch13 C580Y mutations on the island of New Guinea","volume":"16","author":"Miotto","year":"2020","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2022.102193_bib54","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/infdis\/jiaa687","article-title":"Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda","volume":"223","author":"Asua","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_sbref53","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/cid\/ciaa628","article-title":"Clinical and in vitro resistance of Plasmodium falciparum to artesunate-amodiaquine in Cambodia","volume":"73","author":"Mairet-Khedim","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_bib56","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00276-21","article-title":"Pyronaridine-artesunate (Pyramax) for treatment of artemisinin- and piperaquine-resistant Plasmodium falciparum in the central highlands of Vietnam","volume":"65","author":"Manh","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2022.102193_bib57","doi-asserted-by":"crossref","first-page":"17031","DOI":"10.1038\/nmicrobiol.2017.31","article-title":"Mefloquine targets the Plasmodium falciparum 80S ribosome to inhibit protein synthesis","volume":"2","author":"Wong","year":"2017","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.mib.2022.102193_bib58","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.3390\/ijms22116057","article-title":"Selection of pfcrt K76 and pfmdr1 N86 coding alleles after uncomplicated malaria treatment by artemether-lumefantrine in Mali","volume":"22","author":"Maiga","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.mib.2022.102193_bib59","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1645\/19-199","article-title":"Selection of PfCRT 76T and PfMDR1 86Y mutant Plasmodium falciparum after treatment of uncomplicated malaria with artesunate-amodiaquine in Republic of Guinea","volume":"107","author":"Beavogui","year":"2021","journal-title":"J Parasitol"},{"key":"10.1016\/j.mib.2022.102193_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11553","article-title":"Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies","volume":"7","author":"Veiga","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2022.102193_bib61","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-016-1358-z","article-title":"The Plasmodium falciparum chloroquine resistance transporter is associated with the ex vivo P. falciparum African parasite response to pyronaridine","volume":"9","author":"Madamet","year":"2016","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.mib.2022.102193_bib62","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S0140-6736(04)16767-6","article-title":"Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number","volume":"364","author":"Price","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.mib.2022.102193_bib63","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02093-20","article-title":"Expansion of a specific Plasmodium falciparum PfMDR1 haplotype in Southeast Asia with increased substrate transport","volume":"11","author":"Cal\u00e7ada","year":"2020","journal-title":"mBio"},{"key":"10.1016\/j.mib.2022.102193_bib64","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1038\/s41467-020-17781-6","article-title":"The natural function of the malaria parasite's chloroquine resistance transporter","volume":"11","author":"Shafik","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2022.102193_bib65","first-page":"65","article-title":"The knock-down of the chloroquine resistance transporter PfCRT is linked to oligopeptide handling in Plasmodium falciparum","volume":"Jul 18","author":"Sanchez","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.mib.2022.102193_sbref64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001616","article-title":"Mechanistic basis for multidrug resistance and collateral drug sensitivity conferred to the malaria parasite by polymorphisms in PfMDR1 and PfCRT","volume":"20","author":"Shafik","year":"2022","journal-title":"PLoS Biol"},{"key":"10.1016\/j.mib.2022.102193_bib67","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1093\/infdis\/jiab055","article-title":"Distribution and temporal dynamics of Plasmodium falciparum chloroquine resistance transporter mutations associated with piperaquine resistance in northern Cambodia","volume":"224","author":"Shrestha","year":"2021","journal-title":"J Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_bib68","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01121-21","article-title":"Evolution of multidrug resistance in Plasmodium falciparum: a longitudinal study of genetic resistance markers in the Greater Mekong Subregion","volume":"65","author":"Imwong","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.mib.2022.102193_bib69","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100685118","article-title":"Mapping partner drug resistance to guide antimalarial combination therapy policies in sub-Saharan Africa","volume":"118","author":"Ehrlich","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2022.102193_bib70","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1016\/S2666-5247(20)30094-X","article-title":"Molecular surveillance of antimalarial partner drug resistance in sub-Saharan Africa: a spatial-temporal evidence mapping study","volume":"1","author":"Ehrlich","year":"2020","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.mib.2022.102193_sbref69","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1016\/S2666-5247(21)00085-9","article-title":"Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study","volume":"2","author":"Tumwebaze","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.mib.2022.102193_bib72","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04104-z","article-title":"Plasmepsin II-III copy number accounts for bimodal piperaquine resistance among Cambodian Plasmodium falciparum","volume":"9","author":"Bopp","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2022.102193_bib73","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1473-3099(19)30689-9","article-title":"Multigenic architecture of piperaquine resistance trait in Plasmodium falciparum","volume":"20","author":"Silva","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05652-0","article-title":"Emerging Southeast Asian PfCRT mutations confer Plasmodium falciparum resistance to the first-line antimalarial piperaquine","volume":"9","author":"Ross","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.mib.2022.102193_bib75","doi-asserted-by":"crossref","first-page":"11672","DOI":"10.1073\/pnas.1507142112","article-title":"Adaptive evolution of malaria parasites in French Guiana: reversal of chloroquine resistance by acquisition of a mutation in pfcrt","volume":"112","author":"Pelleau","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.mib.2022.102193_bib76","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010278","article-title":"Evidence for the early emergence of piperaquine-resistant Plasmodium falciparum malaria and modeling strategies to mitigate resistance","volume":"18","author":"Small-Saunders","year":"2022","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.mib.2022.102193_bib77","doi-asserted-by":"crossref","first-page":"e00303","DOI":"10.1128\/mBio.00303-17","article-title":"A variant PfCRT isoform can contribute to Plasmodium falciparum resistance to the first-line partner drug piperaquine","volume":"8","author":"Dhingra","year":"2017","journal-title":"mBio"},{"key":"10.1016\/j.mib.2022.102193_bib78","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s41586-019-1795-x","article-title":"Structure and drug resistance of the Plasmodium falciparum transporter PfCRT","volume":"576","author":"Kim","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.mib.2022.102193_bib79","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/s42003-021-02210-1","article-title":"The power and promise of genetic mapping from Plasmodium falciparum crosses utilizing human liver-chimeric mice","volume":"4","author":"Button-Simons","year":"2021","journal-title":"Commun Biol"},{"key":"10.1016\/j.mib.2022.102193_bib80","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.pt.2021.02.007","article-title":"Genomic and genetic approaches to studying antimalarial drug resistance and Plasmodium biology","volume":"37","author":"Okombo","year":"2021","journal-title":"Trends Parasitol"},{"key":"10.1016\/j.mib.2022.102193_bib81","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-017-2130-3","article-title":"Towards malaria elimination in Savannakhet, Lao PDR: mathematical modelling driven strategy design","volume":"16","author":"Tun","year":"2017","journal-title":"Malar J"},{"key":"10.1016\/j.mib.2022.102193_bib82","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-4467-4","article-title":"Mass campaigns combining antimalarial drugs and anti-infective vaccines as seasonal interventions for malaria control, elimination and prevention of resurgence: a modelling study","volume":"19","author":"Camponovo","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.mib.2022.102193_bib83","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51773","article-title":"Determinants of MDA impact and designing MDAs towards malaria elimination","volume":"9","author":"Gao","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.mib.2022.102193_sbref82","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(20)30552-3","article-title":"Triple artemisinin-based combination therapies versus artemisinin-based combination therapies for uncomplicated Plasmodium falciparum malaria: a multicentre, open-label, randomised clinical trial","volume":"395","author":"van der Pluijm","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mib.2022.102193_bib85","doi-asserted-by":"crossref","DOI":"10.1186\/s12936-022-04115-8","article-title":"Malaria chemoprevention and drug resistance: a review of the literature and policy implications","volume":"21","author":"Plowe","year":"2022","journal-title":"Malar J"}],"container-title":["Current Opinion in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527422000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1369527422000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T05:55:57Z","timestamp":1761285357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1369527422000777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":85,"alternative-id":["S1369527422000777"],"URL":"https:\/\/doi.org\/10.1016\/j.mib.2022.102193","relation":{},"ISSN":["1369-5274"],"issn-type":[{"value":"1369-5274","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasmodium falciparum resistance to artemisinin-based combination therapies","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mib.2022.102193","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102193"}}